An American project to develop a 'comprehensive vaccine' that targets multiple breeds of viruses

US Health Agencies announced on Thursday that they want to develop a comprehensive vaccine technology aimed at various breeds of different viruses, such as flu and Corona viruses, as part of a project, the Wall Street Journal reported that it included an investment of $ 500 million. The project, launched by the US Department of Health, bears the name “Generation Gold Standard”, and is aimed at developing a comprehensive vaccine technology that at the same time provides protection against various strains of the virus itself. According to the report “Wall Street Journal”, this project, which was announced in collaboration between the Ministry of Health and the National Health institutions, is a transformation of financing from the Cofide-19 control projects to other viruses study. It is expected that the clinical trials of the vaccine, a comprehensive anti -influenza, start in 2026, with the US Food and Drug Administration (FDA) its decision on the year 2029, according to the Ministry of Health. A spokesman for the US Department of Health said the project provides “an effective and accountable effective alternative,” compared to the ‘Corona virus’ vaccines and treatments. The ministry, led by Robert F. Kennedy Junior, known for his suspicion of vaccines, did not reveal the amount of spending assigned to this project. According to the report, the financing of the Government of the Bida Research and Development Authority (Barda), a center of the ministry, will come to be authorized to protect the public from threats such as epidemics.